The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Multiple dopamine D4 receptor variants in the human population
Abstract
The dopamine D4 receptor structurally and pharmacologically resembles the dopamine D2 and D3 receptors. Clozapine, an atypical antipsychotic that is relatively free of the adverse effects of drug-induced parkinsonism and tardive dyskinesia, binds to the D4 receptor with an affinity 10 times higher than to the D2 and D3 receptors. This may explain clozapine's atypical properties. Here we report the existence of at least three polymorphic variations in the coding sequence of the human D4 receptor. A 48-base-pair sequence in the putative third cytoplasmic loop of this receptor exists either as a direct-repeat sequence (D4.2), as a fourfold repeat (D4.4) or as a sevenfold repeat (D4.7). Two more variant alleles were detected in humans. Expression of the complementary DNA for the three cloned receptor variants showed different properties for the long form (D4.7) and the shorter forms (D4.2, D4.4) with respect to clozapine and spiperone binding. To our knowledge, this is the first report of a receptor in the catecholamine receptor family that displays polymorphic variation in the human population. Such variation among humans may underlie individual differences in susceptibility to neuropsychiatric disease and in responsiveness to antipsychotic medication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Functional significance of this polymorphism has been demonstrated [70–75].”
From Genetics of child aggression, a systematic review (2024) · cites this paper as [70]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
A simple and very efficient method for generating cDNA libraries
Gubler, U., & Hoffman, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90230-5 · Cited by 4,461
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A catalogue of splice junction sequences
Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,742
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608
McMaster, G. K., & Carmichael, G. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4835 · Cited by 2,406
Tol, H. H. M. V., Bunzow, J. R., Guan, H., Sunahara, R. K., Seeman, P. M., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,015
Self-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Flagged first, then by citations
1 of the 20 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Chomczynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987). · DOI
- Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning (Cold Spring Harbor Laboratory Press, New York, 1989).
- Budowle, B. & Baechtel, F. S. Appl. theoret. Electrophoresis (in the press).
Cited by
Sorted by citations
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,889
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Ebstein, R. P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E. R., Nemanov, L., Katz, M., & Belmaker, R. H. (1996) · Nature Genetics · doi:10.1038/ng0196-78 · Cited by 1,475
Genetics of attention deficit hyperactivity disorder
Faraone, S. V., & Larsson, H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0070-0 · Cited by 1,338
Benjamin, J., Li, L., Patterson, C. A., Greenberg, B. D., Murphy, D. L., & Hamer, D. H. (1996) · Nature Genetics · doi:10.1038/ng0196-81 · Cited by 1,191
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Are Political Orientations Genetically Transmitted?
Alford, J. R., Funk, C. L., & Hibbing, J. R. (2005) · American Political Science Review · doi:10.1017/s0003055405051579 · Cited by 995
Dopamine receptor pharmacology
Seeman, P. M., & Tol, H. H. M. V. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90323-9 · Cited by 969
Self-citationFaraone, S., Doyle, A., Mick, E., & Biederman, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1052 · Cited by 740
Reward deficiency syndrome: genetic aspects of behavioral disorders
Comings, D. E., & Blum, K. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26022-6 · Cited by 621
Dopamine D4 receptors elevated in schizophrenia
Seeman, P. M., Guan, H., & Tol, H. H. M. V. (1993) · Nature · doi:10.1038/365441a0 · Cited by 627
Self-citationMolecular Diversity of the Dopamine Receptors
Civelli, O., Bunzow, J. R., & Grandy, D. K. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001433 · Cited by 623
Self-citationDopamine receptors and brain function
Jaber, M., Robinson, S. W., Missale, C., & Caron, M. G. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00100-1 · Cited by 594
A hypervariable segment in the human dopamine receptor D4 (DRD4) gene
Lichter, J. B., Barr, C. L., Kennedy, J. L., Tol, H. H. M. V., Kídd, K. K., & Livak, K. J. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.6.767 · Cited by 524
Self-citationDopamine receptors: Molecular biology, biochemistry and behavioural aspects
Jackson, D. M., & Westlind‐Danielsson, A. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90041-8 · Cited by 500
Mice Lacking Dopamine D4 Receptors Are Supersensitive to Ethanol, Cocaine, and Methamphetamine
Rubinstein, M., Phillips, T. J., Bunzow, J. R., Falzone, T. L., Dziewczapolski, G., Zhang, G., Fang, Y., Larson, J. L., McDougall, J. A., Chester, J. A., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80365-7 · Cited by 473
Self-citationSesack, Sr., Aoki, C., & Pickel, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00088.1994 · Cited by 461
The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus
Chang, F., Kídd, K. K., Livak, K. J., PAKSTIS, A. J., & Kídd, K. K. (1996) · Human Genetics · doi:10.1007/s004390050166 · Cited by 438
The dopamine D4 receptor: one decade of research
Oak, J. N., Oldenhof, J., & Tol, H. H. M. V. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00562-8 · Cited by 421
Self-citationMolecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411
“focused on a tandem repeat polymorphism in exon III of DRD4 because in vitro studies have shown that one variant (the 7-repeat allele) produces a blunted response to dopamine.(26,27) Faraone and colleagues(8) conducted a meta analysis of the 7-repeat allele of the exon III polymorphism and found statistically signific…”
BackgroundGenetics of dopamine receptors and drug addiction: a comprehensive review
Foll, B. L., Gallo, A., Strat, Y. L., Lü, L., & Gorwood, P. A. P. M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283242f05 · Cited by 395
The molecular genetic architecture of human personality: beyond self-report questionnaires
Ebstein, R. P. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001814 · Cited by 367
Dopamine, a neurotransmitter, influences the immune system
Basu, S., & Dasgupta, P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00176-9 · Cited by 335
Association between clozapine response and allelic variation in 5-HT2A receptor gene
Arranz, M. J., Collier, D. A., Sodhi, M., Ball, D., Roberts, G. W., Sham, P. C., Kerwin, R. W., Price, J., & Roberts, G. W. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92168-0 · Cited by 334
Comings, D. E., & MacMurray, J. P. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3015 · Cited by 333
Mechanisms of action of atypical antipsychotic drugs: a critical analysis
Kinon, B. J., & Lieberman, J. A. (1996) · Psychopharmacology · doi:10.1007/bf02245602 · Cited by 317
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 328
The genetic basis for smoking behavior: A systematic review and meta-analysis
Munafo, M. R., Clark, T. G., Johnstone, E. C., Murphy, M., & Walton, R. T. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001734030 · Cited by 312
Pharmacogenetics of Psychotropic Drug Response
Malhotra, A. K., Murphy, G. M., & Kennedy, J. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.780 · Cited by 299
Self-citationNovel dopamine receptors half a decade later
Sokoloff, P., & Schwartz, J.-C. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89044-6 · Cited by 295
D2 and D4 dopamine receptor polymorphisms and personality
Noble, E. P., Ozkaragoz, T. Z., Ritchie, T. L., Zhang, X., Belin, T. R., & Sparkes, R. S. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980508)81:3 · Cited by 292
A meta-analysis of the association between DRD4 polymorphism and novelty seeking
Kluger, A. N., Siegfried, Z., & Ebstein, R. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001082 · Cited by 281
Johnson, W. G. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990820)88:4 · Cited by 33
Neurobiology of retinal dopamine in relation to degenerative states of the tissue
Djamgoz, M. B. A., Hankins, M. W., Hirano, J., & Archer, S. N. (1997) · Vision Research · doi:10.1016/s0042-6989(97)00129-6 · Cited by 274
Beauchaine, T. P., Klein, D. N., Crowell, S. E., Derbidge, C. M., & Gatzke‐Kopp, L. M. (2009) · Development and Psychopathology · doi:10.1017/s0954579409000418 · Cited by 279
Eisenberg, D. T. A., MacKillop, J., Modi, M. E., Beauchemin, J., Dang, D., Lisman, S. A., Lum, J. K., & Wilson, D. S. (2007) · Behavioral and Brain Functions · doi:10.1186/1744-9081-3-2 · Cited by 264
Population studies of polymorphisms of the serotonin transporter protein gene.
Gelernter, J. E., Cubells, J. F., Kidd, J. R., PAKSTIS, A. J., & Kídd, K. K. (1999) · PubMed · Cited by 256
Animal models of attention-deficit hyperactivity disorder.
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00274-6 · Cited by 250
Association of the Dopamine Transporter Gene (DAT1) With Poor Methylphenidate Response
Winsberg, B. G., & Comings, D. E. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00006 · Cited by 242
Strange, P. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01483-2 · Cited by 249
Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors
Seeman, P. M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00187-x · Cited by 236
Self-citationGenetics of Attention Deficit Hyperactivity Disorder
Mick, E. O., & Faraone, S. V. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.011 · Cited by 237
Strous, R. D., Bark, N. M., Parsia, S. S., Volavka, J., & Lachman, H. M. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)03111-3 · Cited by 217
Renal Dopamine Receptors in Health and Hypertension
José, P. A., Eisner, G. M., & Felder, R. A. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00027-8 · Cited by 215
The human dopamine D4 receptor repeat sequences modulate expression
Schoots, O., & Van Tol, H. H. M. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500208 · Cited by 213
Doyle, A. E., Faraone, S. V., Seidman, L. J., Willcutt, E. G., Nigg, J. T., Waldman, I. D., Pennington, B. F., Peart, J., & Biederman, J. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01476.x · Cited by 222
Molecular and cellular genetics of fragile X syndrome
Kaufmann, W. E., & Reiss, A. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1 · Cited by 88
Arbelle, S., Benjamin, J., Golin, M., Kremer, I., Belmaker, R. H., & Ebstein, R. P. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.671 · Cited by 205
Ward, R. P., Hamblin, M. W., Lachowicz, J. E., Hoffman, B. J., Sibley, D. R., & Dorsa, D. M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00439-c · Cited by 199
Eisenberg, D. T. A., Campbell, B., Gray, P. B., & Sorenson, M. D. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-173 · Cited by 197
Pharmacogenetics and psychopharmacotherapy
Poolsup, Po, A. L. W., & Knight (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00281.x · Cited by 197
Dopamine D2 Receptors as Treatment Targets in Schizophrenia
Seeman, P. M. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.1.5 · Cited by 193
Self-citationFilbey, F. M., Ray, L. A., Smolen, A., Claus, E. D., Audette, A., & Hutchison, K. E. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00692.x · Cited by 195
New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine
Brunello, N., MASOTTO, C., Steardo, L., Markstein, R., & Racagni, G. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00068-o · Cited by 190
Gelernter, J. E., Kranzler, H. R., Coccaro, E. F., Siever, L. J., New, A. S., & Mulgrew, C. L. (1997) · The American Journal of Human Genetics · doi:10.1086/301595 · Cited by 188
Medical therapy for clinically non-functioning pituitary adenomas
Colao, A., Somma, C. D., Pivonello, R., Faggiano, A., Lombardi, G., & Savastano, S. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0181 · Cited by 186
Hameg, A., Bayle, F., Nuss, P., Dupuis, P., Garay, R. P., & Dib, M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01515-0 · Cited by 185
Neurobehavioral foundation of environmental reactivity.
Moore, S. R., & Depue, R. A. (2015) · Psychological Bulletin · doi:10.1037/bul0000028 · Cited by 183
The National Longitudinal Study of Adolescent Health (Add Health) Twin Data
Harris, K. M., Halpern, C. T., Smolen, A., & Haberstick, B. C. (2006) · Twin Research and Human Genetics · doi:10.1375/183242706779462787 · Cited by 178
Can genetic factors influence the likelihood of engaging in entrepreneurial activity?
Nicolaou, N., & Shane, S. A. (2008) · Journal of Business Venturing · doi:10.1016/j.jbusvent.2007.11.003 · Cited by 185
Polymorphisms in dopamine receptors: what do they tell us?
Wong, A. H. C., Buckle, C. E., & Tol, H. H. M. V. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00815-3 · Cited by 176
Self-citationRoman, T., Schmitz, M. D., Polanczyk, G. V., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1408 · Cited by 171
The National Longitudinal Study of Adolescent Health (Add Health) Twin Data
Harris, K. M., Halpern, C. T., Smolen, A., & Haberstick, B. C. (2006) · Twin Research and Human Genetics · doi:10.1375/twin.9.6.988 · Cited by 170
Sasaki, J. Y., Kim, H. S., Mojaverian, T., Kelley, L. D. S., Park, I. Y., & Janušonis, S. (2011) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsr089 · Cited by 173
Genetics of adult attention-deficit/hyperactivity disorder
Faraone, S. V. (2004) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00090-x · Cited by 166
Lakatos, K., Tóth, I., Nemoda, Z., Ney, K., Sasvári‐Székely, M., & Gervai, J. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000773 · Cited by 167
Resilience and the brain: a key role for regulatory circuits linked to social stress and support
Holz, N. E., Tost, H., & Meyer-Lindenberg, A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0551-9 · Cited by 162
Dopamine Receptor Genetic Variation, Psychosis, and Aggression in Alzheimer Disease
Sweet, R. A., Nimgaonkar, V. L., Kamboh, M. I., López, O. L., Zhang, F., & DeKosky, S. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.10.1335 · Cited by 164
Polypeptide variants of beta-arrestin and arrestin3
Sterne‐Marr, R., Gurevich, V. V., Goldsmith, P. K., Bodine, R. C., Sanders, C. R., Donoso, L. A., & Benovic, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82304-3 · Cited by 163
Dopamine D4 Receptor Gene Novelty or Nonsense?
Paterson, A. D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00115-8 · Cited by 163
The DRD4 VNTR polymorphism moderates craving after alcohol consumption.
Hutchison, K. E., McGeary, J. E., Smolen, A., Bryan, A. D., & Swift, R. M. (2002) · Health Psychology · doi:10.1037/0278-6133.21.2.139 · Cited by 162
Human fear conditioning is related to dopaminergic and serotonergic biological markers.
Garpenstrand, H., Annas, P., Ekblom, J., Oreland, L., & Fredrikson, M. G. (2001) · Behavioral Neuroscience · doi:10.1037//0735-7044.115.2.358 · Cited by 163
A Genetic Polymorphism in the Promoter Region of DRD4 Associated with Expression and Schizophrenia
Okuyama, Y., Ishiguro, H., Toru, M., & Arinami, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0630 · Cited by 161
Novel insights in dopamine receptor physiology
Pivonello, R., Ferone, D., Lombardi, G., Colao, A., Lamberts, S. W. J., & Hofland, L. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02353 · Cited by 160
The New Atypical Antipsychotics
Kerwin, R. W. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.2.141 · Cited by 160
Friendships Moderate an Association Between a Dopamine Gene Variant and Political Ideology
Settle, J. E., Dawes, C. T., Christakis, N. A., & Fowler, J. H. (2008) · The Journal of Politics · doi:10.1017/s0022381610000617 · Cited by 173
Dopamine genes and attention-deficit hyperactivity disorder: a review
DiMaio, S., Grizenko, N., & Joober, R. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0303 · Cited by 153
The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta-analysis
López‐León, S., Croes, E. A., Sayed‐Tabatabaei, F. A., Claes, S. J., Broeckhoven, C. V., & van Duijn, C. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.030 · Cited by 156
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease
Scheller, D., Ullmer, C., Berkels, R., Gwarek, M., & Lübbert, H. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0341-4 · Cited by 151
Clinical and Molecular Genetics of ADHD and Tourette Syndrome
Comings, D. E. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05773.x · Cited by 152
Neurochemistry and Neuroendocrinology of Schizophrenia: A Selective Review
Lieberman, J. A., & Koreen, A. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.371 · Cited by 149
Genes Associated With Addiction: Alcoholism, Opiate, and Cocaine Addiction
Kreek, M. J., Nielsen, D. A., & LaForge, K. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:085 · Cited by 149
The Genetics of Fibromyalgia Syndrome
Buskila, D., Sarzi‐Puttini, P., & Ablin, J. N. (2006) · Pharmacogenomics · doi:10.2217/14622416.8.1.67 · Cited by 146
Boehmler, W., Carr, T., Thisse, C., Thisse, B., Canfield, V. A., & Levenson, R. G. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00243.x · Cited by 146
Blum, K., Liu, Y., Wang, W., Wang, Y., Zhang, Y., Oscar‐Berman, M., Smolen, A., Febo, M., Han, D. C., Simpatico, T. A., et al. (2014) · Postgraduate Medicine · doi:10.1080/00325481.2015.994879 · Cited by 144
Fonagy, P. (2003) · Infant Mental Health Journal · doi:10.1002/imhj.10053 · Cited by 156
Serotonin receptor cDNA cloned from Lymnaea stagnalis.
Sugamori, K. S., Sunahara, R. K., Guan, H. C., Bulloch, A. G., Tensen, C. P., Seeman, P. M., Niznik, H. B., & Tol, H. H. M. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.11 · Cited by 141
Self-citationWeeland, J., Overbeek, G., de Castro, B. O., & Matthys, W. (2015) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-015-0196-4 · Cited by 138
Neto, L. V., Machado, E. D. O., Luque, R. M., Taboada, G. F., Marcondes, J. B., Chimelli, L. M. C., Quintella, L. P., Niemeyer, P., de Carvalho, D. P., Kineman, R. D., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1826 · Cited by 139
Karwautz, A. F. K., Rabe‐Hesketh, S., HU, X., Zhao, J., Sham, P. C., Collier, D. A., & Treasure, J. L. (2001) · Psychological Medicine · doi:10.1017/s0033291701003129 · Cited by 139
Full-length cDNA cloning and distribution of human dopamine D4 receptor
Matsumoto, M., Hidaka, K., Tada, S., Tasaki, Y., & Yamaguchi, T. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00245-a · Cited by 139
Dopamine D4 receptor subtypes and response to clozapine
Shaikh, S., Collier, D., Kerwin, R. W., Pilowsky, L. S., Gill, M., Xu, W.-M., & Thornton, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)92594-j · Cited by 138
Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N. R., Bowman, E. D., & Shields, P. G. (1998) · Health Psychology · doi:10.1037//0278-6133.17.1.56 · Cited by 198
The dopaminergic system in hypertension
Zeng, C., Zhang, M., Asico, L. D., Eisner, G. M., & José, P. A. (2007) · Clinical Science · doi:10.1042/cs20070018 · Cited by 137
The DRD4 VNTR polymorphism influences reactivity to smoking cues.
Hutchison, K. E., LaChance, H., NIAURA, R. S., Bryan, A. D., & Smolen, A. (2002) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.111.1.134 · Cited by 134
Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species.
Livak, K. J., Rogers, J., & Lichter, J. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.427 · Cited by 133
Seeking a mechanism of action for the novel anticonvulsant lacosamide
Errington, A. C., Coyne, L., Stöhr, T., Selve, N., & Lees, G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.02.002 · Cited by 132
Molecular Characteristics of Mammalian Dopamine Receptors
Lachowicz, J. E., & Sibley, D. R. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00039.x · Cited by 132
Metadata
- Authors
- Tol, H. H. M. V., Wu, C. M., Guan, H.-C., Ohara, K., Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B., & Jovanovic, V.
- Affiliations
- University of Toronto (CA)
- Oregon Health & Science University (US)
- Venue
- Nature
- Published
- 1992-07
- Volume
- 358
- Issue
- 6382
- Pages
- 149-152
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2026395566
- Cited by
- 955
- References
- 20
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 10 · 2021: 14 · 2020: 43 · 2019: 15 · 2018: 7 · 2017: 12 · 2016: 32 · 2015: 34 · 2014: 26 · 2013: 23 · 2012: 35
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- dopamine D4 receptor, genetic polymorphism, receptor isoforms, spiperone binding, direct repeats, cytoplasmic loop, atypical antipsychotics, individual differences in drug response
- MeSH terms
- Base Sequence, Binding, Competitive, Cell Line, Clozapine, DNA, DNA Restriction Enzymes, Humans, Introns, Molecular Sequence Data, Pituitary Gland, Receptors, Dopamine, Repetitive Sequences, Nucleic Acid, Spiperone, Substantia Nigra, Transfection, Genetic Variation, Gene Expression, Receptors, Dopamine D2, Receptors, Dopamine D4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review